Trials / Completed
CompletedNCT02429856
Posterior Cruciate Retaining (PCR) Versus Posterior Cruciate Substituting (PCS) Total Knee Arthroplasty (TKA)
SCORPIO™ Posterior Stabilized Versus Posterior Retained Total Knee Arthroplasties: Long-term Functional and Radiographic Outcome
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 100 (actual)
- Sponsor
- University of Alberta · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This randomized clinical trial (RCT) examined 10 year outcomes comparing SCORPIO™ Posterior Cruciate Substituting (PCS) versus Posterior Cruciate Retaining (PCR) Total Knee Arthroplasty (TKA) as the primary outcome.
Detailed description
RCT of 100 subjects undergoing primary TKA who were randomized to received either a SCORPIO™ PCS or PCR TKA. Subjects were evaluated pre-operatively and at 2 and 10 years post-operatively using the Western Ontario (WOMAC) Osteoarthritis Index, the RAND-36 and knee range of motion (2 years only). Complication and revision rates were also evaluated.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | SCORPIO™ | subjects randomized at surgery to receive 1 of the 2 specified implants |
Timeline
- Start date
- 1999-02-01
- Primary completion
- 2013-05-01
- Completion
- 2013-05-01
- First posted
- 2015-04-29
- Last updated
- 2021-07-27
- Results posted
- 2019-05-13
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT02429856. Inclusion in this directory is not an endorsement.